End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
519 KRW | -2.81% | 0.00% | -32.95% |
18/03 | OLIPASS Corporation announced that it has received KRW 3.5 billion in funding | CI |
06/03 | OLIPASS Corporation announced that it expects to receive KRW 5 billion in funding | CI |
Chart calendar OLIPASS Corporation
Upcoming events on OLIPASS Corporation
No events available
Past events on OLIPASS Corporation
13/05/2024 | Q1 2024 Earnings Release (Projected) |
15/05/2023 | Q1 2023 Earnings Release |
20/03/2023 | Q4 2022 Earnings Release |
14/11/2022 | Q3 2022 Earnings Release |
16/08/2022 | Interim 2022 Earnings Release |
16/05/2022 | Q1 2022 Earnings Release |
13/08/2021 | Interim 2021 Earnings Release |
17/05/2021 | Q1 2021 Earnings Release |
17/03/2021 | FY 2020 Earnings Release |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 |
---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 0,49 | 0,00 0,00 - | 2,86 4,00 -28.48% |
EBITDA Billions KRW | Released Forecast Spread | 0,00 | -18,5 23,0 -180.63% | -20,5 -20,0 -2.41% |
EBIT Billions KRW | Released Forecast Spread | 0,00 | -21,5 20,0 -207.54% | -23,7 -23,0 -3.04% |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 | -46,4 20,0 -332.13% | -24,6 -25,0 1.68% |
Net income Billions KRW | Released Forecast Spread | 0,00 | -45,6 27,0 -269.04% | -24,6 -25,0 1.68% |
EPS KRW | Released Forecast Spread | 0,00 | -1 977 1 323 -249.42% | -980 -1 015 3.42% |
Announcement Date | 01/04/19 | 17/03/20 | 05/03/21 |
16/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 06:30 pm | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
24/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
25/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
25/07/2024 10:30 am | ARGENX SE: Q2 2024 Earnings Release |
30/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
30/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
30/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
31/07/2024 | CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for OLIPASS Corporation
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- A244460 Stock
- Calendar OLIPASS Corporation